title: Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: rkanema@juntendo.ac.jp.
authors: Ryota
authors: R
authors: Kanemaru
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: ymorio@juntendo.ac.jp.
authors: Yoshiteru
authors: Y
authors: Morio
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: htakekaw@juntendo.ac.jp.
authors: Hidenori
authors: H
authors: Takekawa
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: jo@juntendo.ac.jp.
authors: Hitomi
authors: H
authors: Jo
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: ffujiwa@juntendo.ac.jp.
authors: Fumiko
authors: F
authors: Kasuga
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: rkoyama@juntendo.ac.jp.
authors: Ryo
authors: R
authors: Koyama
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: sshiota@juntendo.ac.jp.
authors: Satomi
authors: S
authors: Shiota
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: jnagaoka@juntendo.ac.jp.
authors: Tetsutaro
authors: T
authors: Nagaoka
authors: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-Ku, Tokyo 113-8431, Japan. Electronic address: kztakaha@juntendo.ac.jp.
authors: Kazuhisa
authors: K
authors: Takahashi
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology*; D066246:ErbB Receptors / Q000235:genetics*; D000069347:Erlotinib Hydrochloride / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology*; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D009154:Mutation
chemical_list: D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors